Literature DB >> 34145485

MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.

Ningmin Zhao1, Qing Luo1, Ruijuan Lin1, Qiaoyan Li1, Peizhi Ma2.   

Abstract

BACKGROUND: Tubular injury plays a crucial role in the pathogenesis of diabetic nephropathy (DN). It is well known that many microRNAs (miRNAs) exert crucial effects on tubular injury. This study intends to explore the effect of miR-142-3p on the apoptosis and oxidative stress of high glucose (HG)-treated renal tubular epithelial cells (HK-2) and its underlying mechanism.
MATERIALS AND METHODS: HK-2 cells were exposed to HG to mimic cell injury. MTT assays and flow cytometry analyses were conducted to measure cell viability and cell apoptosis, respectively. RT-qPCR and western blot analyses were carried out to detect RNA and protein levels, respectively. The levels of oxidative stress markers were evaluated by ELISA. The binding between miR-142-3p and biorientation of chromosomes in cell division 1 (BOD1) was validated by a luciferase reporter assay. RESULT: MiR-142-3p is low-expressed in HG-stimulated HK-2 cells. Functionally, miR-142-3p overexpression attenuates the apoptosis and oxidative stress of HG-stimulated HK-2 cells. Mechanistically, BOD1 was confirmed to be targeted by miR-142-3p in HK-2 cells. Moreover, BOD1 overexpression reversed the suppressive effect of miR-142-3p overexpression on the apoptosis and oxidative stress of HK-2 cells treated with HG.
CONCLUSION: MiR-142-3p ameliorates HG-induced renal tubular epithelial cell injury by targeting BOD1. The finding might provide novel insight into the role of miR-142-3p/BOD1 axis in DN treatment.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  BOD1; Diabetic nephropathy; Renal tubular epithelial cell injury; miR-142-3p

Mesh:

Substances:

Year:  2021        PMID: 34145485     DOI: 10.1007/s10157-021-02102-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.617


  49 in total

Review 1.  [Pathophysiology of diabetic nephropathy: a literature review].

Authors:  Carlos Eduardo Meza Letelier; Camilo Alfredo San Martín Ojeda; José Javier Ruiz Provoste; Cristobal Jesus Frugone Zaror
Journal:  Medwave       Date:  2017-01-12

Review 2.  Overview of microRNA biology.

Authors:  Ashley M Mohr; Justin L Mott
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 3.  Diabetic nephropathy in type 1 diabetes.

Authors:  Nektaria Papadopoulou-Marketou; Stavroula A Paschou; Nikolaos Marketos; Sofia Adamidi; Sotiris Adamidis; Christina Kanaka-Gantenbein
Journal:  Minerva Med       Date:  2017-12-04       Impact factor: 4.806

Review 4.  MicroRNAs: a new ray of hope for diabetes mellitus.

Authors:  Munish Kumar; Sayantan Nath; Himanshu K Prasad; G D Sharma; Yong Li
Journal:  Protein Cell       Date:  2012-10-11       Impact factor: 14.870

Review 5.  MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications.

Authors:  Romano Regazzi
Journal:  Expert Opin Ther Targets       Date:  2017-12-22       Impact factor: 6.902

Review 6.  Fine-tuning of microRNAs in Type 2 Diabetes Mellitus.

Authors:  Juan A Rosado; Raquel Diez-Bello; Ginés M Salido; Isaac Jardin
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 7.  Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.

Authors:  Nektaria Papadopoulou-Marketou; George P Chrousos; Christina Kanaka-Gantenbein
Journal:  Diabetes Metab Res Rev       Date:  2016-10-04       Impact factor: 4.876

Review 8.  Update of pathophysiology and management of diabetic kidney disease.

Authors:  Yi-Chih Lin; Yu-Hsing Chang; Shao-Yu Yang; Kwan-Dun Wu; Tzong-Shinn Chu
Journal:  J Formos Med Assoc       Date:  2018-03-02       Impact factor: 3.282

Review 9.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

Review 10.  Classification and Differential Diagnosis of Diabetic Nephropathy.

Authors:  Chenyang Qi; Xing Mao; Zhigang Zhang; Huijuan Wu
Journal:  J Diabetes Res       Date:  2017-02-20       Impact factor: 4.011

View more
  3 in total

1.  Identification of Genes Reveals the Mechanism of Cell Ferroptosis in Diabetic Nephropathy.

Authors:  Xian Wang; Ling Jiang; Xue-Qi Liu; Yue-Bo Huang; Wei Zhu; Han-Xu Zeng; Li Gao; Li-Juan Ma; Meng-Ya Zhang; Qi-Jin Zhu; Yong-Gui Wu
Journal:  Front Physiol       Date:  2022-05-26       Impact factor: 4.755

2.  MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway.

Authors:  Li Cheng; Xinying Qiu; Liyu He; Li Liu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

Review 3.  Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?

Authors:  Weronika Kraczkowska; Lucyna Stachowiak; Andrzej Pławski; Paweł Piotr Jagodziński
Journal:  J Appl Genet       Date:  2022-01-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.